Technology Framework
Navigene leverages an agile, yet robust, 3-layer technology framework built around US FDA approved, gold standard diagnostic instruments. We enhance this foundation with proprietary protocols governing sample collection, processing techniques and robotic automation. And finally, AIpowered diagnostic and reporting software. The result is a platform engineered for multiplex, faster, cost effective, and highly accurate diagnostics—all without compromise.

Core Layer: Gold-Standard Instruments – Our laboratory is equipped with state-of-the-art analytical instruments. All equipment and methodologies are compliant with U.S. FDA standards, ensuring the highest levels of accuracy and reliability in diagnostic testing. These platforms enable precise quantification and identification of multiple biomarkers, and metabolites, of diagnostic significance in a single test supporting a wide range of clinical and research applications.
Proprietary Layer: Proprietary Methods – We employ Dried Urine Spot (DUS) and Dried Blood Spot (DBS) techniques for sample collection, offering a minimally invasive, patient-friendly approach that simplifies logistics and enhances sample stability during transportation. Our proprietary protocols, developed and refined over years of research, significantly reduce processing time and increase throughput, thereby improving turnaround time (TAT) for the test reports. By integrating cross-technology methodologies, we can extract multiple diagnostic markers in a single test from a single DUS/DBS sample (multiplex testing) and achieve deeper analytical insights, facilitating comprehensive evaluations of complex biological samples.
Analytical Layer: AI Powered Insights – Navisys AI makes medical testing faster, smarter, and more cost-effective. Using advanced machine learning, our solutions cut false positives by up to 80–90%, reducing unnecessary repeat tests and easing patient anxiety. Our platform quickly analyzes complex biomarker patterns, uncovers new disease markers, and delivers more accurate results—saving both time and resources. Navisys AI’s clinical decision support systems combine lab results with patient and demographic data to give doctors clear, actionable next steps. This improves treatment accuracy, reduces reliance on scarce specialists, and ensures better outcomes, especially in large-scale public health programs.